Administration of RAS Inhibitor before the Onset of Diabetic Nephropathy Counteracts the Adverse Effect of Chronic Hyperglycemia and Reduces the Augmentation of Urinary Albumin Excretion: A Retrospective Clinical Study

Table 2

Association between the alteration of urinary albumin excretion and various clinical parameters: multivariate analysis.

	Control group		RAS inhibitor group
HbA1c, annual mean	7.574	<0.005	−1.749	n.s.
Age, baseline	0.208	n.s.	0.171	n.s.
Systolic BP, annual mean	−0.021	n.s.	0.165	n.s.
Gender	0.533	n.s.	1.017	n.s.
eGFR, baseline	0.019	n.s.	0.142	n.s.

Abbreviations: n.s., not significant; BP, blood pressure; RAS, renin-angiotensin system.